Mehdi Lahmar - Dissemin

All papers authored by Mehdi Lahmar

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Supplementary Figure 1 from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Supplementary Figure 2 from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Supplementary Methods from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Supplementary Table 2 from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Supplementary Table 1 from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer

, Junxian Geng, Teffany Davenport

, Michael Teufel

, Jian Li, Mehdi Lahmar

, Mrinal M. Gounder

Data from The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

Upload

This paper is made freely available by the publisher.

Patrick Schöffski, Mehdi Lahmar

, Anthony Lucarelli, Robert G. Maki

Brightline-1: phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS

Download from doi.org

2021 Jean-Marc Barret

, André Nicolas, Anne Jarry

, Olivier Dubreuil, Didier Meseure, Tilda Passat, Emeline Perrial, Cécile Deleine, Gabriel Champenois, Solenne Gaillard, Emilie Duchalais, Isabelle Ray-Coquard

, Mehdi Lahmar

, Charles Dumontet, Jaafar Bennouna and 3 other authors

The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2015 Françoise Aubrit, Fabien Perugi, Arnaud Léon, Fabienne Guéhenneux, Patrick Champion-Arnaud, Mehdi Lahmar

, Klaus Schwamborn

Cell substrates for the production of viral vaccines

Upload

2007 Medhi Lahmar

, Cyril Catelain, Sonia Poirault, Marion Dorsch, Jean-Luc Villeval, William Vainchenker

, Olivier Albagli, Evelyne Lauret

Distinct Effects of the Soluble Versus Membrane-Bound Forms of the Notch Ligand Delta-4 on Human CD34+CD38low Cell Expansion and Differentiation

Download from onlinelibrary.wiley.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Mehdi Lahmar